WO2002060349A2 - Expandable stent with array of relief cuts - Google Patents

Expandable stent with array of relief cuts Download PDF

Info

Publication number
WO2002060349A2
WO2002060349A2 PCT/US2001/040331 US0140331W WO02060349A2 WO 2002060349 A2 WO2002060349 A2 WO 2002060349A2 US 0140331 W US0140331 W US 0140331W WO 02060349 A2 WO02060349 A2 WO 02060349A2
Authority
WO
WIPO (PCT)
Prior art keywords
stent
relief cuts
members
relief
artery
Prior art date
Application number
PCT/US2001/040331
Other languages
French (fr)
Inventor
Ulf Harry Stanford
Original Assignee
Ulf Harry Stanford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulf Harry Stanford filed Critical Ulf Harry Stanford
Publication of WO2002060349A2 publication Critical patent/WO2002060349A2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91566Adjacent bands being connected to each other connected trough to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • the present invention relates generally to balloon expandable and self-
  • the present invention provides an array of relief cuts for use in a variety of stent designs. According to the present
  • the relief cuts are strategically placed to allow the stent to expand
  • the present invention allows the use of wider and thinner material, resulting in a stent with greater radio-opacity, and resulting in a thinner walled stent allowing
  • FIG. 4A illustrates a typical prior art diamond-shaped cell configuration utilizing the cross sections illustrated in Figs.
  • a third disadvantage is limited coverage of the vessel wall by the stent.
  • the stent according to the present invention, as illustrated in Figs. 4D, 4E and 4G, is designed to expand under the same balloon pressure as the stent designs illustrated in Figs. 4A-4C and 4H.
  • a compressive load i.e., its hoop strength in the case of a stent.
  • each individual relief cut has a relatively short length in order to preserve the ability of the member to retain its columnar
  • the present invention avoids the cost and disadvantages of electro-polishing; furthermore, the present invention inherently allows the use of wider and thinner,
  • a stent is placed in a curved section of an artery (or other lumen). As the balloon is expanded, the stent tends to straighten, causing the curved portion
  • the present invention facilitates expansion of a stent in a curved artery by
  • the relief cuts reduce the tendency of the stent to
  • Another significant aspect of the present invention is that selective placement of an array of relief cuts on a stent allows the stent to expand in a predetermined and controlled non-uniform fashion. For example, placing an array of relief cuts only in the longitudinal center region of the stent causes the
  • relief cuts can be utilized only at the
  • relief cuts may be applied in various patterns to cause stents to act differently; some patterns allow stents to be used better in curved and tapered
  • claimed herein can quickly provide existing commercial stents with most, if not
  • Another object of the invention is to provide an array of relief cuts in prior
  • Still another object of the invention is to provide a balloon expandable and self-expandable stent design having an array of relief cuts which in turn
  • Still a further object of the invention is to provide an array of relief cuts
  • thinner wall stents thereby increasing the effective inner diameter of arteries and other lumens carrying those stents.
  • a still further object of the invention is to provide selective placement of
  • Figs. 1 A-E are schematic representations showing relief cuts according
  • Fig. 2 is a schematic representation illustrating how the relief cuts of the
  • Fig. 3 is a schematic representation showing how the relief cuts of the present invention may be applied to a prior art stent configuration having an
  • Figs. 4A-4C and 4F illustrate a prior art, diamond-shaped stent cell
  • FIG. 4B and 4C showing the cross section of the stent of Fig. 4A;
  • Figs. 4D, 4E and 4G illustrate how the present invention as applied to the
  • diamond-shaped cell of Figs. 4A-4C and 4E achieves a wider, thinner stent, with a larger interior diameter allowing less turbulent blood flow;
  • Fig. 4H illustrates the cross section of a typical prior art stent having a
  • Figs. 5A-5D illustrate how the relief cuts of the present invention may be applied strategically to the distal and proximal ends of a stent, thereby causing
  • Figs. 6A-6C are schematic representations illustrating how a pattern of
  • Fig. 7 is a schematic representation showing how the relief cuts of the
  • Figs. 8A and 8B are schematic illustrations representing how the present invention could be utilized to seal off the blood flow to and kill a cancerous tumor;
  • Fig. 9 is a schematic representation showing how relief cuts of the present invention may be used in a prior art stent having a single strand
  • serpentine-shaped stent illustrating how the present invention is usable in prior
  • Fig. 10 is a schematic representation of an alternate embodiment of the
  • Fig. 11 A illustrates schematically how relief cuts may be patterned for use
  • Fig. 11 B is a section on the line 11 B-11 B of Fig. 11 A;
  • Fig. 12A is a schematic representation showing still another way in which
  • relief cuts may be patterned on a stent for use in a curved artery or other body
  • Fig. 12B is a sectional view on the line 12B-12B of Fig. 12A;
  • Fig. 13A shows another embodiment wherein relief cuts are placed only
  • Fig. 13B is a sectional view on the line 13B-13B of Fig. 13A;
  • Fig. 14A is yet another embodiment showing relief cuts applied only to the
  • Fig. 14B is a section on the line 14B-14B of Fig. 14A;
  • Figs. 15A and 15B are schematic illustrations showing how the present invention may be used with bifurcated stents;
  • Figs. 16A and 16B are schematic illustrations showing how the present invention may be used in an irregularly shaped artery (or other lumen);
  • FIGs. 17A and 17B are schematic illustrations showing one way in which
  • the present invention may be utilized in an artery (or other lumen) having a branch artery (or lumen) at or near the deployment site of the stent;
  • Figs. 18A and 18B are schematic illustrations showing a second way in which the present invention may be utilized in an artery (or other lumen) having
  • Figs. 19A and 19B illustrate how the present invention may be utilized in a stent having cells which expand in different directions as the stent expands.
  • Figs. 1A-1 E illustrate how a conventional, diamond-shaped stent cell 10
  • Fig. 1A illustrates a diamond-shaped cell 10 having upper members
  • Connection points 18 and 19 extend along the longitudinal axis of the stent.
  • first and second cuts 31 and 32 each formed either in the apexes or connections between members or at the point in which the primary amount of flexing or bending occurs to allow the stent to expand.
  • the relief cuts are formed either in the apexes or connections between members or at the point in which the primary amount of flexing or bending occurs to allow the stent to expand.
  • Fig. 1 A are arcuate cuts that extend completely through the particular members
  • Fig. 1 B illustrates the same stent cell configuration as Fig. 1A but illustrates a second form of relief cuts 35 which include a plurality of circular cuts
  • FIG. 1 C illustrates a third
  • relief cuts 40 are elliptical relief cuts 41 and 42.
  • Fig. 1D illustrates a fourth type of relief cut 45 which includes a plurality
  • Fig. 1 E illustrates a fifth form of relief cut 50 including a first plurality 51
  • FIG. 2 illustrates a second stent cell configuration 110 having a "butterfly" shape including a first butterfly wing 111 and a second butterfly wing 112.
  • plurality of arcuate relief cuts 131-138 are formed strategically at those places of the cell configuration wherein maximum bending and flexing is intended to
  • Fig. 2 illustrates the arcuate slotted relief cut. Alternately, the circular
  • Figs. 1 B and 1 C could be utilized in the cell configuration shown in Fig. 2.
  • Fig. 3 illustrates the application of the present invention to a third type of
  • Cell 150 is generally a sinusoidal wall cell
  • Relief cuts 151 are formed between adjacent members 152 and
  • Figs. 4A-4H are intended to illustrate how the present invention can be
  • FIG. 1 illustrate the prior art diamond-shaped cell configuration 10 illustrated in Fig. 1.
  • FIGS. 4B and 4C show one typical cross section of members 12 and 15 as being of circular cross
  • FIG. 4H illustrates a second typical prior art cross section as generally square with
  • rounded corners formed by electro-polishing having a thickness t x and width w
  • Fig. 4F shows in exaggerated fashion a cross section of an artery 9 in which a
  • stent having the cell configuration shown in Fig. 4A has been placed.
  • Member 12 is illustrated having a circular cross section and supporting vessel wall 9. As shown in Fig. 4F, the central unobstructed portion of artery 9 has a diameter d 1
  • Figs. 4D, 4E and 4G illustrate a modified diamond-shaped cell
  • width w 2 is also greater than
  • Width w 2 is preferably
  • Each stent member 12a has the general configuration illustrated in Fig. 4E and is shown in place within the same arterial wall 9
  • each stent member 12a allows a larger diameter d 2 which represents the
  • the effective volume of less turbulent laminar blood flow varies with the square of the
  • Figs. 5A-5D illustrate how the present invention may be utilized to cause
  • a stent to expand at its distal and proximal ends before it expands in its center
  • a stent 210 is shown positioned in an artery 9 adjacent plaque deposit
  • the central region 211 of stent 210 is positioned adjacent the plaque deposit
  • the central region 211 of stent 210 has no relief cuts formed therein.
  • distal region 212 of stent 210 has a plurality of relief cuts shown generally as 230 formed therein.
  • proximal end 213 of stent 210 has a plurality
  • stent 210 may be any type of balloon expandable stent, including stent cell configurations illustrated in Figs. 1-3 as
  • expandable stent designs preferably at the points of those stent designs where the maximum flexing and bending are designed to occur to allow the stent to expand.
  • the invention may also be used in self-expanding stents, as discussed
  • the stent 210 illustrated generically in Fig. 5A is intended to include any
  • Fig. 5D illustrates typical balloon pressures; the distal and proximal ends 230,231 expand with 8 atm
  • Fig. 5D is presented only as an example.
  • Figs. 6A-6C illustrate a stent configuration 250 having no relief cuts at its distal end 251 or at its proximal end 252.
  • Stent 250 does have a plurality of
  • This feature can be advantageous in preventing longitudinal motion of the stent relative to the artery as it expands.
  • Fig. 7 illustrates yet another sinusoidal stent configuration 260 with relief
  • Figs. 8A-8B illustrate how the present invention may be utilized to starve a cancerous tumor 6 fed by an artery 9.
  • a stent 270 is placed in the artery close
  • Stent 270 has relief cuts formed only in its distal end
  • Stent 270 carries an impermeable covering sheath 279 and, as its distal
  • end 271 expands and contacts the walls of artery 9, blood flow through artery
  • Fig. 9 illustrates how the present invention may be used with a
  • stent is widely used in the art and is illustrated separately since it does not use a closed cell design but, nevertheless, may benefit significantly from the present
  • Relief cuts 281 are formed in serpentine stent 280 at the intended points of maximum flex or bending as the stent is expanded. Using the relief cuts as illustrated in Fig. 9 will allow the stent to expand in response to less
  • Fig. 10 illustrates another variation of the invention wherein stent 290 has
  • relief cuts 291 and 292 are aligned transversely across the width of
  • This embodiment of the invention is particularly useful for
  • width is available to position the relief cuts transversely.
  • Figs. 11-14 illustrate various techniques by which the relief cuts of the
  • FIG. 11A illustrates an artery 9 having a curved region 5. Artery 9 is assumed to lie in a plane parallel with the drawing.
  • Stent 310 is shown positioned in artery 9 in its expanded position. Stent 310
  • the distal section 311 has a distal section 311 , a proximal section 312 and a central section 313.
  • distant and proximal sections each carries a pattern of relief cuts illustrated by dashed lines 315 and 316, respectively.
  • Central section 313 of stent 310 does
  • relief cuts 315 and 316 are not formed around the entire periphery of stent 310, as illustrated in sectional view 11 B. As shown in sectional view 11 B, relief cuts 315 are formed in the upper part and lowermost part of stent 310; however, no relief cuts are formed near the horizontal axis A illustrated in Fig. 11 B. The effect of placing relief cuts as illustrated in Fig. 11 B is to allow stent 310 to bend
  • Figs. 12A and 12B illustrate a variation to the relief cut pattern shown in
  • Stent 350 illustrated in Fig. 12 has relief cuts 355 formed along its
  • central region 353 as well as distal and proximal ends
  • Fig. 12B to facilitate its placement and deployment in the curved artery 9.
  • Figs. 13A and 13B illustrate yet another manner in which relief cuts may
  • the pattern of relief cuts 415 is only formed in the central region 413 of stent 410.
  • Central section 413 has relief cuts formed completely and uniformly around its periphery as illustrated in sectional view 13B. Placement of relief cuts around the entire periphery of the central
  • region 413 allows maximum flexibility of stent 410 in the region where stent 410 must bend to conform to the curved region 5 of artery 9.
  • Figs. 14A and 14B illustrate stent 450 having a pattern of relief cuts 455
  • Figs. 15A and 15B are schematic illustrations showing how the present
  • a first prior art stent 470 is placed in artery
  • a second stent 9 has an extension 471 that extends partially into branch 2.
  • the distal end 481 of stent 480 is positioned inside stent 470 prior to being
  • stent 480 As shown in Fig. 15B, as stent 480 is expanded, its distal end 481 forms a "flare" 482 which effectively seats against stent 470 and which prevents stents 470 and 480 from separating after being deployed.
  • Figs. 16A and 16B are schematic illustrations showing how the present invention can be utilized in arteries or other lumens having somewhat irregular
  • Artery 109 is shown having a first section 109a of rather large diameter
  • Plaque deposit 108 is illustrated in the generally tapered region of artery 109.
  • Stent 510 which can be any prior art stent or any stent shown and described in the parent application referred to above.
  • Stent 510 has a distal end 511 and a
  • proximal end 512 proximal end 512.
  • a rather large number of relief cuts 515 are formed in proximal end 512 of stent 510.
  • a somewhat smaller number of relief cuts is
  • patterns of relief cuts on stent 510 is to cause the stent 510 in its expanded position to conform as closely as possible to the walls of the artery 109 and the
  • distal end 511 expands a somewhat reduced amount because of the absence
  • FIGs. 16A and 16B illustrate how patterns of relief cuts can be utilized to make a stent expand in a
  • the stent in its expanded form effectively supports the irregularly
  • Figs. 17A and 17B are schematic illustrations showing how the present invention may be utilized in an artery or other lumen having a branch artery at
  • Artery 209 has a first
  • a branch artery 212 connects to artery
  • Stent 550 is provided having a distal end 551
  • proximal end 552 Since the proximal end 552 must expand a greater distance than the distal end 551 , a relatively large number of relief cuts 555 is
  • a secondary pattern 557 of relief cuts is applied so that the stent may expand to a somewhat greater degree adjacent the distal end 207 of plaque
  • Stent 550 is shown in its expanded form in Fig. 17B and it can be
  • Figs. 18A and 18B show an alternate stent design 610 which may be
  • Stent 610 has a proximal end 611
  • stent 610 extends beyond the proximal end of stent 610
  • Stent 610 has an
  • opening 614 formed in its surface adjacent where stent 610 will expand against the base of branch artery 212.
  • the opening 614 in stent 610 allows blood to flow freely from artery 209 into branch artery 212.
  • Stent 610 has a greater
  • relief cuts 616 formed at its distal end.
  • a tapering pattern of relief cuts 617 is
  • the relief cut patterns are designed to allow the stent to expand in a controlled, non-uniform manner to conform to the wall of the
  • Fig. 19A illustrates a prior art stent design 650 shown in U.S. patent No. 6,159,237, wherein the stent includes transverse cells 651 and 652.
  • the stent includes transverse cells 651 and 652.
  • Fig. 19B shows the relief cuts of the present invention as applied to the
  • Relief cuts 655 allow stent 650 to expand radially in a first direction to increase its circumference. Relief cuts 656 in transverse
  • cells 651 and 652 allow cells 651 and 652 to expand more easily in a second
  • Fig. 19B illustrates how the present
  • relief cuts 655 may be used without using relief cuts 656.
  • the invention is also useful with self-expanding stents.
  • self-expanding stents the use of relief cuts allows the use of flatter and thinner walled stents, increasing the radio-opacity and vessel wall coverage of the stent. Furthermore, using patterns of relief cuts in self-
  • those stents may be caused to expand in a controlled, non-
  • the present invention is usable with stents made of any material such as

Abstract

An array of relief cuts is formed at the flexion points of an expandable stent. The relief cuts are small enough to preserve the columnar compressive strength of the stent. The relief cuts allow a balloon expandable stent to be expanded with less balloon pressure. The relief cuts allow the use of wider and thinner material in the sten, giving greater radio-opacity and vessel coverage while simultaneously reducing the stent profile and increasing laminar blood flow through the stented vessel. Patterns of relief cuts may be placed in stents to achieve controlled, non-unifrom expansion and which, in some instances, allow the stent to bend easily in a given direction to facilitate deployment in curved arteries or other body lumens.

Description

EXPANDABLE STENT WITH ARRAY OF RELIEF CUTS CROSS-REFERENCE TO RELATED APPLICATION This is a continuation-in-part of U.S. patent application Serial No.
09/357,699 filed July 20, 1999 and entitled EXPANDABLE STENT. BACKGROUND AND BRIEF SUMMARY OF THE INVENTION
The present invention relates generally to balloon expandable and self-
expanding stents. More particularly, the present invention provides an array of relief cuts for use in a variety of stent designs. According to the present
invention, the relief cuts are strategically placed to allow the stent to expand
more easily, requiring less pressure for the expansion, without any significant
loss of columnar compressive strength of the members making up the stent. The present invention allows the use of wider and thinner material, resulting in a stent with greater radio-opacity, and resulting in a thinner walled stent allowing
maximum blood flow through the artery or other lumen.
The prior art stent designs typically use stent members or struts having
circular cross sections as illustrated in Figs. 4B, 4C and 4F or generally square
cross sections as illustrated in Fig. 4H. Fig. 4A illustrates a typical prior art diamond-shaped cell configuration utilizing the cross sections illustrated in Figs.
4B, 4C, 4F and 4H. The prior art configurations illustrated in Figs. 4A-4C and
4H have several disadvantages. First, as the stents are downsized for use in smaller vessels, the circular or cross sections of the stent material tends to
effectively reduce the cross-sectional area of the artery or other body lumen
which is capable of achieving low turbulence or laminar blood flow. A second
disadvantage of this typical prior art design is that, in many instances, particularly as the stent size is reduced, the radio-opacity of the stent, i.e., the
capability of the stent to be viewed by the surgeon, is reduced. A third disadvantage is limited coverage of the vessel wall by the stent. The present
invention is designed to overcome these problems by providing a wider and
thinner material, as illustrated generally in Figs. 4D, 4E and 4G, which provides enhanced radio-opacity, enhanced vessel wall coverage but at the same time
providing a stent that will expand as easily as the prior art stent. For example,
the stent, according to the present invention, as illustrated in Figs. 4D, 4E and 4G, is designed to expand under the same balloon pressure as the stent designs illustrated in Figs. 4A-4C and 4H.
The prior art also includes International Application No. PCT/US99/06136
published October 7, 1999 as publication No. WO 99/49810. That published
application discloses a "double-strut" stent configuration with a plurality of
closed cells wherein each member of the cell configuration is slotted throughout
its entire length. The inherent weakness of this design is that each fully slotted
cell member becomes significantly weakened by the use of slots extending
throughout its entire length. The compressive strength of each member is
substantially weakened as shown by the "critical load" analysis as an "Euler
column" as established mathematically by Leonard Euler. The removal of
approximately one-third of the material along the center of a column and
throughout the entire length of the column greatly reduces its ability to support
a compressive load, i.e., its hoop strength in the case of a stent.
In contrast to the "double-strut" design described in the above-identified
PCT International application, the present invention utilizes an array of strategically placed relief cuts. Each individual relief cut has a relatively short length in order to preserve the ability of the member to retain its columnar
compressive strength.
It is also known in the prior art to electro-polish portions of a stent to reduce the cross-sectional area of a stent member so that less balloon pressure is required to expand the stent. The electro-polishing technique is expensive
and has the inherent weakness of reducing the radio-opacity of the polished
portion of the stent. It is important to maximize the radio-opacity of the stent,
especially as smaller stents are used in smaller arteries and other body lumens. The present invention avoids the cost and disadvantages of electro-polishing; furthermore, the present invention inherently allows the use of wider and thinner,
more radio-opaque stent members.
Another significant problem with most prior art stent designs arises when
a stent is placed in a curved section of an artery (or other lumen). As the balloon is expanded, the stent tends to straighten, causing the curved portion
of the artery (or other lumen) to straighten and sometimes rupturing the vessel
wall. The present invention facilitates expansion of a stent in a curved artery by
using curved balloons and applying relief cuts in selected, predetermined
patterns to the stent. The relief cuts reduce the tendency of the stent to
straighten as the stent and balloon are expanded.
A further limitation of prior art stents is that the typical stent expands at
a uniform rate as balloon pressure is applied. There are many practical instances where a controlled non-uniform expansion of a stent would be a
significant advantage. Another significant aspect of the present invention is that selective placement of an array of relief cuts on a stent allows the stent to expand in a predetermined and controlled non-uniform fashion. For example, placing an array of relief cuts only in the longitudinal center region of the stent causes the
center region of the stent to expand first before the distal and proximal regions
of the stent expand. As another example, relief cuts can be utilized only at the
distal and proximal end regions of the stent, which causes the end regions to
expand first, with the central region of the stent expanding last. As a further example, relief cuts may be applied in various patterns to cause stents to act differently; some patterns allow stents to be used better in curved and tapered
vessels, some patterns allow one or both ends of the stent to be "flared," and
some patterns allow the stent to bend more easily in a given direction.
Another advantage of the present invention is that the relief cuts may be
applied to a variety of existing and commercially successful balloon expandable and self-expanding stent designs. The use of the relief cuts as described and
claimed herein can quickly provide existing commercial stents with most, if not
all, of the advantages of the present invention.
It is therefore a primary object of the present invention to provide an array
of relief cuts in a balloon expandable stent to allow the stent to expand more easily and with less pressure, without any significant loss of the columnar
compressive strength of the stent members in which the cuts are formed.
Another object of the invention is to provide an array of relief cuts in prior
art stent designs to allow those stents to expand more easily and with less
pressure than is the case in the absence of relief cuts. Still another object of the invention is to provide a balloon expandable and self-expandable stent design having an array of relief cuts which in turn
allows the use of wider and thinner members in the stent to increase the radio-
opacity and vessel wall coverage of the stent, while using thinner wall members. Still a further object of the invention is to provide an array of relief cuts
which not only allows the use of wider members, but also allows the use of
thinner wall stents, thereby increasing the effective inner diameter of arteries and other lumens carrying those stents. The use of thinner walled stents
minimizes the profile or cross section of the stent and provides more clearance in inserting and deploying the stent.
A still further object of the invention is to provide selective placement of
one or more arrays of relief cuts to a stent, which allows the stent to expand in
a predetermined and controlled non-uniform fashion. This feature allows a stent
to be custom designed to an artery to better support the arterial wall and to seal
end leaks.
Other objects and advantages of the present invention will become
apparent from the following description and the drawings wherein:
BRIEF DESCRIPTION OF THE DRAWINGS
Figs. 1 A-E are schematic representations showing relief cuts according
to the present invention as applied to a generally diamond-shaped prior art stent
cell configuration;
Fig. 2 is a schematic representation illustrating how the relief cuts of the
present invention may be applied to a prior art "butterfly" stent cell configuration; Fig. 3 is a schematic representation showing how the relief cuts of the present invention may be applied to a prior art stent configuration having an
undulating or sinusoidal -type cell configuration;
Figs. 4A-4C and 4F illustrate a prior art, diamond-shaped stent cell, with
Figs. 4B and 4C showing the cross section of the stent of Fig. 4A;
Figs. 4D, 4E and 4G illustrate how the present invention as applied to the
diamond-shaped cell of Figs. 4A-4C and 4E achieves a wider, thinner stent, with a larger interior diameter allowing less turbulent blood flow;
Fig. 4H illustrates the cross section of a typical prior art stent having a
generally square shape with rounded corners formed by electro-polishing;
Figs. 5A-5D illustrate how the relief cuts of the present invention may be applied strategically to the distal and proximal ends of a stent, thereby causing
those ends of the stent to expand before the central portion of the stent
expands; Figs. 6A-6C are schematic representations illustrating how a pattern of
relief cuts placed only in the central portion of a stent will cause that center
portion of the stent to expand before the end portions;
Fig. 7 is a schematic representation showing how the relief cuts of the
present invention as applied to only the central portion of a prior art stent
configuration will cause a predetermined, controlled, uneven expansion of the
stent;
Figs. 8A and 8B are schematic illustrations representing how the present invention could be utilized to seal off the blood flow to and kill a cancerous tumor; Fig. 9 is a schematic representation showing how relief cuts of the present invention may be used in a prior art stent having a single strand
serpentine-shaped stent, illustrating how the present invention is usable in prior
art stents which do not have closed cell configurations;
Fig. 10 is a schematic representation of an alternate embodiment of the
invention, showing transversely spaced relief cuts for use primarily on stents having relatively wide members;
Fig. 11 A illustrates schematically how relief cuts may be patterned for use
on a stent to be placed in a curved artery or other body lumen wherein no relief
cuts are placed in the central region of the stent;
Fig. 11 B is a section on the line 11 B-11 B of Fig. 11 A; Fig. 12A is a schematic representation showing still another way in which
relief cuts may be patterned on a stent for use in a curved artery or other body
lumen;
Fig. 12B is a sectional view on the line 12B-12B of Fig. 12A;
Fig. 13A shows another embodiment wherein relief cuts are placed only
in the central region of a stent and around the entire periphery of the stent for
use in a curved artery and
Fig. 13B is a sectional view on the line 13B-13B of Fig. 13A; Fig. 14A is yet another embodiment showing relief cuts applied only to the
central region of the stent for use in a curved artery wherein the relief cuts are placed away from the inside radius of curvature of the artery;
Fig. 14B is a section on the line 14B-14B of Fig. 14A; Figs. 15A and 15B are schematic illustrations showing how the present invention may be used with bifurcated stents;
Figs. 16A and 16B are schematic illustrations showing how the present invention may be used in an irregularly shaped artery (or other lumen);
Figs. 17A and 17B are schematic illustrations showing one way in which
the present invention may be utilized in an artery (or other lumen) having a branch artery (or lumen) at or near the deployment site of the stent;
Figs. 18A and 18B are schematic illustrations showing a second way in which the present invention may be utilized in an artery (or other lumen) having
a branch artery (or lumen) at or near the deployment site of the stent; and
Figs. 19A and 19B illustrate how the present invention may be utilized in a stent having cells which expand in different directions as the stent expands.
DETAILED DESCRIPTION OF THE DRAWINGS
Figs. 1A-1 E illustrate how a conventional, diamond-shaped stent cell 10
may be provided with relief cuts of various shapes according to the present
invention. Fig. 1A illustrates a diamond-shaped cell 10 having upper members
11 and 12 connected at their intersection 13 and lower members 14 and 15
connected at their intersection 16. As the stent cell 10 expands, members 12
and 15 flex or bend relative to each other at their connection point 18. Similarly,
members 11 and 14 bend or flex relative to each other about their connection
point or apex 19. Connection points 18 and 19 extend along the longitudinal axis of the stent.
According to the present invention, a plurality of relief cuts shown
generally as 30 includes first and second cuts 31 and 32, each formed either in the apexes or connections between members or at the point in which the primary amount of flexing or bending occurs to allow the stent to expand. The relief cuts
of the present invention may also be utilized in stents which do not use a closed cell configuration, as described below. The relief cuts 31 and 32 illustrated in
Fig. 1 A are arcuate cuts that extend completely through the particular members
of stent 10. Placement of one or more of the relief cuts 31 and 32 at or near at least one designed flexion or bending point of the particular stent configuration
allows the stent to expand in response to considerably less balloon pressure.
Fig. 1 B illustrates the same stent cell configuration as Fig. 1A but illustrates a second form of relief cuts 35 which include a plurality of circular cuts
36 and 37, preferably positioned at those points of the stent design which are
intended to flex or bend to allow the stent to expand. Fig. 1 C illustrates a third
embodiment wherein the relief cuts 40 are elliptical relief cuts 41 and 42.
Fig. 1D illustrates a fourth type of relief cut 45 which includes a plurality
of triangular shaped cuts 46 and a second plurality of triangular cuts 47.
Applicant believes that, although the triangular relief cuts would perform the
intended function of allowing the stent to expand with less balloon pressure,
those are not the preferred designs. The applicant believes the designs having sharp corners in the relief cuts may eventually cause cracking of the stent
material as the stent expands.
Fig. 1 E illustrates a fifth form of relief cut 50 including a first plurality 51
and a second plurality 52 of generally rectangular or square shaped cuts.
Again, these are less preferable than the rounded cuts illustrated in Figs. 1 A-C
but, nevertheless, are within the scope of the invention. Fig. 2 illustrates a second stent cell configuration 110 having a "butterfly" shape including a first butterfly wing 111 and a second butterfly wing 112. A
plurality of arcuate relief cuts 131-138 are formed strategically at those places of the cell configuration wherein maximum bending and flexing is intended to
occur between the individual members of the cell configuration 110 as the stent expands. Fig. 2 illustrates the arcuate slotted relief cut. Alternately, the circular
or elliptical relief cuts illustrated in Figs. 1 B and 1 C could be utilized in the cell configuration shown in Fig. 2.
Fig. 3 illustrates the application of the present invention to a third type of
prior art cell configuration 150. Cell 150 is generally a sinusoidal wall cell
configuration. Relief cuts 151 are formed between adjacent members 152 and
153. Members 152 and 153 are intended to flex or bend at their connection point 154 as the stent cell 150 expands. Relief cuts 151 , according to the
present invention, are a series of round holes placed at this region of maximum
flexion or bending to allow the stent to expand in response to reduced balloon
pressure.
Figs. 4A-4H are intended to illustrate how the present invention can be
applied to a prior art cell configuration, and these figures illustrate some of the
significant advantages that the present invention provides. Figs. 4A-4C and 4H
illustrate the prior art diamond-shaped cell configuration 10 illustrated in Fig. 1.
As shown in Fig. 4A, the cell configuration is shown as it is used in the prior art,
i.e., without any of the relief cuts of the present invention. Figs. 4B and 4C show one typical cross section of members 12 and 15 as being of circular cross
section and having a thickness t, and width wx that are equal to each other. Fig. 4H illustrates a second typical prior art cross section as generally square with
rounded corners formed by electro-polishing, having a thickness tx and width w
Fig. 4F shows in exaggerated fashion a cross section of an artery 9 in which a
stent having the cell configuration shown in Fig. 4A has been placed. Member 12 is illustrated having a circular cross section and supporting vessel wall 9. As shown in Fig. 4F, the central unobstructed portion of artery 9 has a diameter d1
which is the diameter of the stented artery capable of supporting low turbulence
or laminar blood flow, for a given degree of expansion of artery 9
Figs. 4D, 4E and 4G illustrate a modified diamond-shaped cell
configuration 10a incorporating the present invention. A series of circular relief cuts 37 are shown at the intersection 18a of cell members 12a and 15a and
illustrated best in Fig. 4E and are much wider and much thinner than the prior
art cross sections shown in Figs. 4B, 4C and 4H. The width w2 is considerably
greater than the width w, of members 12 and 15; width w 2 is also greater than
the thickness t2 of the modified cell configuration 10a. Width w2 is preferably
between 1.5 and 5 times as great as thickness t2. However, it is significant to
note that, because of the presence of relief cuts 37, the modified cell configuration 10a will expand in response to the same balloon pressure or less
balloon pressure required to expand the prior art cell configuration 10. The
presence of relief cuts 37 in the cell configuration allows the use of much wider
and thinner members 12a and 15a of the stent. A further significant advantage is illustrated in Fig. 4G. Each stent member 12a has the general configuration illustrated in Fig. 4E and is shown in place within the same arterial wall 9
expanded to the same extent as illustrated in Fig. 4F. The reduced thickness of each stent member 12a allows a larger diameter d2 which represents the
unobstructed inner diameter of the stented artery capable of supporting less turbulent blood flow. Any increase in this diameter is very significant,
particularly as smaller diameter or diseased vessels are considered. The effective volume of less turbulent laminar blood flow varies with the square of the
diameter d2 so that the difference illustrated between Figs. 4F and 4G
represents an approximately 50% increase in theoretical volumetric low turbulence, laminar blood flow in the stented artery for the same degree of
expansion. Reduction of turbulence provides the added benefit of reduced
blood clotting, since turbulent blood flow tends to create blood clots. As noted above, the increased width of the stent members increases radio-opacity as well
as increases contact with the vessel wall as illustrated in Fig. 4G.
Figs. 5A-5D illustrate how the present invention may be utilized to cause
a stent to expand at its distal and proximal ends before it expands in its center
region. A stent 210 is shown positioned in an artery 9 adjacent plaque deposit
8. The central region 211 of stent 210 is positioned adjacent the plaque deposit
8. The central region 211 of stent 210 has no relief cuts formed therein. The
distal region 212 of stent 210 has a plurality of relief cuts shown generally as 230 formed therein. Similarly, the proximal end 213 of stent 210 has a plurality
of relief cuts 231 formed therein. For the sake of illustration purposes, the relief
cuts 230 and 231 in Figs. 5A-5D are simply shown as cross hatching or dashed
lines. It is to be understood that stent 210 may be any type of balloon expandable stent, including stent cell configurations illustrated in Figs. 1-3 as
well as a variety of other known stent configurations. For example, The Stenter's Notebook published by Physicians' Press in 1998 and written by Paul S. Phillips, M.D., Morton J. Kern, M.D. and Patrick W. Serruys, M.D. illustrates a variety of commercial, balloon expandable stents at pages 181 -206. Those pages are herein incorporated by reference as though set forth in full herein. It is to be understood that the relief cuts according to the present invention may be utilized in any of the balloon expandable stent designs illustrated in The
Stenter's Notebook. Some of those stent designs do not use a plurality of closed cells, but rather use single wire shapes formed in a variety of ways. Each of those designs has the common feature that a portion of the stent is designed
to flex or bend to allow the stent to expand. It is within the scope of the present
invention to apply the relief cuts of this invention to any of those prior art balloon
expandable stent designs, preferably at the points of those stent designs where the maximum flexing and bending are designed to occur to allow the stent to expand. The invention may also be used in self-expanding stents, as discussed
below.
The stent 210 illustrated generically in Fig. 5A is intended to include any
of the stent configurations illustrated in The Stenter's Notebook, which are
balloon expandable as well as those configurations illustrated in Figs. 1 -3
herein, and those shown and described in parent application Serial No.
09/357,699, incorporated herein by reference as though set forth in full. With
the relief cuts formed at the distal and proximal ends 230 and 231 , respectively, as the balloon (not shown for clarity) expands, the distal and proximal ends 230
and 231 expand first as illustrated in Fig. 5B. This feature can be very important
since, as illustrated in Fig. 5B, the distal portion 230 and proximal portion 231 of the stent will contact the vessel wall 9 before the central region of the stent 211 contacts the plaque deposit 8, thereby tending to "trap" the plaque deposit in its present position. As illustrated in Fig. 5C, the central region 211 of the
stent which does not have any relief cuts requires somewhat additional pressure
to expand and is shown in its expanded position where it contacts plaque deposit 8 and expands the restricted part of the artery. Fig. 5D illustrates typical balloon pressures; the distal and proximal ends 230,231 expand with 8 atm
pressure and central section 211 expands at 10 atm pressure. Other expansion
pressures can be used; Fig. 5D is presented only as an example.
Figs. 6A-6C illustrate a stent configuration 250 having no relief cuts at its distal end 251 or at its proximal end 252. Stent 250 does have a plurality of
relief cuts 255 according to the present invention at its central region 254. As shown in Fig. 6B, the central region 254 having the relief cuts expands first.
This feature can be advantageous in preventing longitudinal motion of the stent relative to the artery as it expands.
Fig. 7 illustrates yet another sinusoidal stent configuration 260 with relief
cuts 265 formed only in its central region 261. That central region 261 will
expand prior to the distal and proximal regions 262 and 263, respectively.
Figs. 8A-8B illustrate how the present invention may be utilized to starve a cancerous tumor 6 fed by an artery 9. A stent 270 is placed in the artery close
to the cancerous tumor 6. Stent 270 has relief cuts formed only in its distal end
271. Stent 270 carries an impermeable covering sheath 279 and, as its distal
end 271 expands and contacts the walls of artery 9, blood flow through artery
9 to tumor 6 is interrupted, causing the tumor to die. Fig. 9 illustrates how the present invention may be used with a
continuous, single strand serpentine stent 280 known in the art. This type of
stent is widely used in the art and is illustrated separately since it does not use a closed cell design but, nevertheless, may benefit significantly from the present
invention. Relief cuts 281 are formed in serpentine stent 280 at the intended points of maximum flex or bending as the stent is expanded. Using the relief cuts as illustrated in Fig. 9 will allow the stent to expand in response to less
balloon pressure. It is to be understood that the serpentine stent design could
also be modified by increasing the width of the serpentine stent member and
decreasing the thickness, in similar fashion as illustrated above in Figs. 4D, 4E and 4G relative to the prior art closed cell diamond-shaped cell configuration.
Fig. 10 illustrates another variation of the invention wherein stent 290 has
relief cuts 291 and 292 formed near apex 295. In the embodiment illustrated in
Fig. 10, relief cuts 291 and 292 are aligned transversely across the width of
stent member 296. This embodiment of the invention is particularly useful for
stents used in larger blood vessels and other body lumens wherein adequate
width is available to position the relief cuts transversely.
Figs. 11-14 illustrate various techniques by which the relief cuts of the
present invention may be used advantageously in curved or angulated arteries
or other body lumens. For example, Fig. 11A illustrates an artery 9 having a curved region 5. Artery 9 is assumed to lie in a plane parallel with the drawing.
Stent 310 is shown positioned in artery 9 in its expanded position. Stent 310
has a distal section 311 , a proximal section 312 and a central section 313. The
distant and proximal sections each carries a pattern of relief cuts illustrated by dashed lines 315 and 316, respectively. Central section 313 of stent 310 does
not have relief cuts formed in it in the embodiment illustrated in Fig. 11 A. The relief cuts 315 and 316 are not formed around the entire periphery of stent 310, as illustrated in sectional view 11 B. As shown in sectional view 11 B, relief cuts 315 are formed in the upper part and lowermost part of stent 310; however, no relief cuts are formed near the horizontal axis A illustrated in Fig. 11 B. The effect of placing relief cuts as illustrated in Fig. 11 B is to allow stent 310 to bend
easily relative to vertical axis B-B in order to accommodate the curved section
5 of artery 9 to facilitate deployment of stent 310. The pattern of relief cuts as illustrated in Figs. 11 A and 11 B tends to maximize the strength of stent 310 in
its central region 313 to resist the crumpling of the curved region 5 of artery 9.
Figs. 12A and 12B illustrate a variation to the relief cut pattern shown in
Fig. 11. Stent 350 illustrated in Fig. 12 has relief cuts 355 formed along its
entire length including central region 353 as well as distal and proximal ends
351 and 352. Again, the relief cuts 355 are only formed away from the
horizontal axis A-A illustrated in Fig. 12B. Placement of the relief cuts in this
fashion allows the stent 350 maximum flexibility to bend about vertical axis B-B
illustrated in Fig. 12B to facilitate its placement and deployment in the curved artery 9.
Figs. 13A and 13B illustrate yet another manner in which relief cuts may
be utilized to facilitate deployment of stent 410 in curved artery 9 having a
curved section 5. In this embodiment, the pattern of relief cuts 415 is only formed in the central region 413 of stent 410. The proximal end and distal end
411 ,412 have no relief cuts formed therein. Central section 413 has relief cuts formed completely and uniformly around its periphery as illustrated in sectional view 13B. Placement of relief cuts around the entire periphery of the central
region 413 allows maximum flexibility of stent 410 in the region where stent 410 must bend to conform to the curved region 5 of artery 9.
Figs. 14A and 14B illustrate stent 450 having a pattern of relief cuts 455
placed only at the central region 453 of stent 450 and only in that portion of the stent periphery which contacts the outside radius of the arterial wall at the
curved section 5. As illustrated in Fig. 14B, relief cuts 455 are placed radially
outwardly of the vertical axis B-B of Fig. 14B and no relief cuts are formed on the inside radius, that is, radially inwardly of the central vertical axis B-B of stent
450. The purpose of placing relief cuts in this fashion is to allow the central portion 453 of stent 450 to flex to conform to the curved portion 5 of artery 9
while simultaneously allowing the stent to remain as rigid as possible adjacent the more sharply curved arterial wall region 4 which occurs at the radial inwardly
side of the curved section of artery 9. The stent is therefore strongest along the
inside radius 4 of curved artery 9, which is the part of the artery most likely to
crimp.
Figs. 15A and 15B are schematic illustrations showing how the present
invention can be used in conjunction with bifurcated stents. A bifurcated artery
9 splits into two branches 2 and 3. A first prior art stent 470 is placed in artery
9 and has an extension 471 that extends partially into branch 2. A second stent
480 is provided having a series of relief cuts 485 formed in its distal end 481.
The distal end 481 of stent 480 is positioned inside stent 470 prior to being
expanded. As shown in Fig. 15B, as stent 480 is expanded, its distal end 481 forms a "flare" 482 which effectively seats against stent 470 and which prevents stents 470 and 480 from separating after being deployed.
Figs. 16A and 16B are schematic illustrations showing how the present invention can be utilized in arteries or other lumens having somewhat irregular
shapes. Artery 109 is shown having a first section 109a of rather large diameter
and a second section 109b having a somewhat reduced diameter. Plaque deposit 108 is illustrated in the generally tapered region of artery 109. A stent
510, which can be any prior art stent or any stent shown and described in the parent application referred to above. Stent 510 has a distal end 511 and a
proximal end 512. A rather large number of relief cuts 515 are formed in proximal end 512 of stent 510. A somewhat smaller number of relief cuts is
formed in the distal end 511 of the stent 510. The purpose of placing these
patterns of relief cuts on stent 510 is to cause the stent 510 in its expanded position to conform as closely as possible to the walls of the artery 109 and the
plaque deposit 108. As shown in Fig. 16B, the proximal end 512 expands
further because of the presence of a greater number of relief cuts 515. The
distal end 511 expands a somewhat reduced amount because of the absence
of relief cuts. The small pattern of relief cuts 516 formed near the distal end 511
causes a somewhat greater expansion of stent 510 in that region to conform to
the shape of the arterial wall and plaque deposit 108. Figs. 16A and 16B illustrate how patterns of relief cuts can be utilized to make a stent expand in a
controlled non-uniform fashion to conform to a somewhat irregularly shaped
arterial wall. The stent in its expanded form effectively supports the irregularly
shaped vessel wall and plaque deposits and simultaneously seals off any leaks that would otherwise occur at the proximal and distal ends of the stent.
Figs. 17A and 17B are schematic illustrations showing how the present invention may be utilized in an artery or other lumen having a branch artery at
or near the location where the stent is to be deployed. Artery 209 has a first
region 210 of relatively large diameter and a second downstream region 211 having a considerably reduced diameter. A branch artery 212 connects to artery
209 near a plaque deposit 208. Stent 550 is provided having a distal end 551
and a proximal end 552. Since the proximal end 552 must expand a greater distance than the distal end 551 , a relatively large number of relief cuts 555 is
placed near proximal end 552. The number of relief cuts is gradually reduced and, at the center of stent 550, a relatively sparse pattern 556 of relief cuts is
applied where the stent should be expanded the least. Towards the distal end
of stent 551 a secondary pattern 557 of relief cuts is applied so that the stent may expand to a somewhat greater degree adjacent the distal end 207 of plaque
deposit 208. Stent 550 is shown in its expanded form in Fig. 17B and it can be
seen that the patterning of relief cuts allows the stent to expand in a controlled
non-uniform fashion to conform to the walls of the artery 209 and to achieve the desired blood flow through artery 209.
Figs. 18A and 18B show an alternate stent design 610 which may be
utilized in the irregular shaped artery 209 illustrated in Figs. 17A and 17B with plaque deposit 208 and branch artery 212. Stent 610 has a proximal end 611
and a distal end 612. The proximal end of stent 610 extends beyond the
location where branch artery 212 connects with artery 209. Stent 610 has an
opening 614 formed in its surface adjacent where stent 610 will expand against the base of branch artery 212. The opening 614 in stent 610 allows blood to flow freely from artery 209 into branch artery 212. Stent 610 has a greater
number of relief cuts 615 formed at its proximal end 611 as compared to the
relief cuts 616 formed at its distal end. A tapering pattern of relief cuts 617 is
formed in the center of stent 610 to allow the stent to conform to the required taper. As shown in Fig. 18B, the relief cut patterns are designed to allow the stent to expand in a controlled, non-uniform manner to conform to the wall of the
artery (or other lumen) and to prevent end leaks.
Fig. 19A illustrates a prior art stent design 650 shown in U.S. patent No. 6,159,237, wherein the stent includes transverse cells 651 and 652. As stent
650 expands, cells 651 and 652 expand along the longitudinal axis A-A of the
stent 650.
Fig. 19B shows the relief cuts of the present invention as applied to the
stent design 650 of Fig. 19A. Relief cuts 655 allow stent 650 to expand radially in a first direction to increase its circumference. Relief cuts 656 in transverse
cells 651 and 652 allow cells 651 and 652 to expand more easily in a second
direction parallel to longitudinal axis A-A. Fig. 19B illustrates how the present
invention can be used to facilitate stent cell expansion in two directions (longitudinally and circumferentially) simultaneously. Alternately, relief cuts 656
in the transverse cells may be utilized without using relief cuts 655; this variation
would allow the transverse cells to expand more easily than the circumferentially expanding cells. Also, relief cuts 655 may be used without using relief cuts 656.
Although the above description of the invention has concentrated on balloon expandable stents, the invention is also useful with self-expanding stents. In the case of self-expanding stents, the use of relief cuts allows the use of flatter and thinner walled stents, increasing the radio-opacity and vessel wall coverage of the stent. Furthermore, using patterns of relief cuts in self-
expanding stents, those stents may be caused to expand in a controlled, non-
uniform fashion which can be advantageous in many situations. Each of the figures illustrated herein, including the various stent cell configurations and the various patterns of relief cuts illustrated in the drawings, may all be applied to self-expanding stents.
The present invention is usable with stents made of any material such as
nitinol, stainless steel, plastic and composite materials.
The foregoing description of the invention has been presented for purposes of illustration and description and is not intended to be exhaustive or
to limit the invention to the precise form disclosed. Many modifications and
variations are possible in light of the above teaching. The embodiments were
chosen and described to best explain the principles of the invention and its
practical application to thereby enable others skilled in the art to best use the
invention in various embodiments and with various modifications suited to the
particular use contemplated. The scope of the invention is defined by the
following claims.

Claims

CLAIMS 1. In an expandable stent, wherein said stent has a plurality of interconnected members, and wherein said interconnected members flex relative to each other as said stent expands, the improvement comprising:
an array of relief cut means formed in some of said interconnected
members whereby said members flex more easily than without said relief cut means, and wherein each of said relief cut means is sufficiently small that the
columnar compressive strength of said interconnected members is not significantly reduced by the presence of said relief cut means formed therein.
2. The apparatus of claim 1 wherein said stent is a balloon
expandable stent.
3. The apparatus of claim 2 wherein said stent has distal and
proximal ends and a central section, and wherein said relief cut means are formed only in said distal and proximal ends.
4. The apparatus of claim 2 wherein said stent has distal and
proximal ends and a central section, and wherein said relief cut means are
formed only in said central section.
5. The apparatus of claim 2 wherein said interconnected members of
said stent have cross sections wherein the width is greater than the thickness.
6. The apparatus of claim 5 wherein said width is between 1.5 and
5 times as great as said thickness.
7. The apparatus of claim 1 wherein said relief cut means comprises
one or more holes formed in and extending through one or more of said interconnecting members.
8. The apparatus of claim 7 wherein said holes are circular.
9. The apparatus of claim 7 wherein said holes are elliptical.
10. The apparatus of claim 7 wherein said holes are slots.
11. The apparatus of claim 1 wherein said stent is a self-expandable
stent.
12. The apparatus of claim 1 wherein said relief cuts are applied to said stent in patterns to allow controlled, non-uniform expansion of said stent.
13. In an expandable stent having a plurality of cells and said stent is
movable between a retracted and an expanded position, wherein said cells are formed by a plurality of flexible, interconnected members, said members flexing
relative to each other as said stent expands, the improvement comprising: an array of relief cut means formed in some of said members to cause said members to flex more easily than without said relief cut means being
formed therein.
14. The apparatus of claim 13 wherein said stent is a balloon-
expandable stent.
15. The apparatus of claim 13 wherein said interconnected members
have cross sections wherein the width is between 1.5 and 5 times as great as
the thickness.
PCT/US2001/040331 2001-01-30 2001-03-20 Expandable stent with array of relief cuts WO2002060349A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/774,760 US20010032011A1 (en) 1999-07-20 2001-01-30 Expandable stent with array of relief cuts
US09/774,760 2001-01-30

Publications (1)

Publication Number Publication Date
WO2002060349A2 true WO2002060349A2 (en) 2002-08-08

Family

ID=25102193

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/040331 WO2002060349A2 (en) 2001-01-30 2001-03-20 Expandable stent with array of relief cuts

Country Status (2)

Country Link
US (1) US20010032011A1 (en)
WO (1) WO2002060349A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8900292B2 (en) 2007-08-03 2014-12-02 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US9284409B2 (en) 2007-07-19 2016-03-15 Boston Scientific Scimed, Inc. Endoprosthesis having a non-fouling surface

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
AU2001253479A1 (en) * 2000-04-13 2001-10-30 Sts Biopolymers, Inc. Targeted therapeutic agent release devices and methods of making and using the same
AU6539101A (en) * 2000-06-05 2001-12-17 G David Jang Intravascular stent with increasing coating retaining capacity
WO2002071975A2 (en) * 2001-03-13 2002-09-19 Yoram Richter Method and apparatus for stenting
AU2002345328A1 (en) 2001-06-27 2003-03-03 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US7014654B2 (en) * 2001-11-30 2006-03-21 Scimed Life Systems, Inc. Stent designed for the delivery of therapeutic substance or other agents
US7163553B2 (en) 2001-12-28 2007-01-16 Advanced Cardiovascular Systems, Inc. Intravascular stent and method of use
EP1348402A1 (en) * 2002-03-29 2003-10-01 Advanced Laser Applications Holding S.A. Intraluminal endoprosthesis, radially expandable, perforated for drug delivery
US20050288769A1 (en) * 2002-06-13 2005-12-29 Oren Globerman Mechanical structures and implants using said structures
US7258697B1 (en) * 2003-12-22 2007-08-21 Advanced Cardiovascular Systems, Inc. Stent with anchors to prevent vulnerable plaque rupture during deployment
EP1895952B1 (en) * 2005-06-15 2020-04-15 Cook Medical Technologies LLC Intraluminal device with unsymmetric tapered beams
WO2006138547A1 (en) * 2005-06-15 2006-12-28 Med Institute, Inc Intraluminal device with improved tapered beams
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
US8771343B2 (en) 2006-06-29 2014-07-08 Boston Scientific Scimed, Inc. Medical devices with selective titanium oxide coatings
EP2054537A2 (en) 2006-08-02 2009-05-06 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
WO2008033711A2 (en) 2006-09-14 2008-03-20 Boston Scientific Limited Medical devices with drug-eluting coating
WO2008034031A2 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprostheses and methods of making the same
JP2010503494A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Biodegradable endoprosthesis and method for producing the same
WO2008034048A2 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprosthesis with biostable inorganic layers
CA2663220A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Medical devices and methods of making the same
EP2068962B1 (en) 2006-09-18 2013-01-30 Boston Scientific Limited Endoprostheses
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
ES2506144T3 (en) 2006-12-28 2014-10-13 Boston Scientific Limited Bioerodible endoprosthesis and their manufacturing procedure
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US8216209B2 (en) 2007-05-31 2012-07-10 Abbott Cardiovascular Systems Inc. Method and apparatus for delivering an agent to a kidney
US9144509B2 (en) 2007-05-31 2015-09-29 Abbott Cardiovascular Systems Inc. Method and apparatus for delivering an agent to a kidney
US9149610B2 (en) 2007-05-31 2015-10-06 Abbott Cardiovascular Systems Inc. Method and apparatus for improving delivery of an agent to a kidney
US9364586B2 (en) 2007-05-31 2016-06-14 Abbott Cardiovascular Systems Inc. Method and apparatus for improving delivery of an agent to a kidney
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8221822B2 (en) 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
WO2009155328A2 (en) 2008-06-18 2009-12-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
CN101732114B (en) * 2008-11-04 2014-07-30 上海微创医疗器械(集团)有限公司 Coronary artery stent with medicine carrying grooves
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
WO2010101901A2 (en) 2009-03-02 2010-09-10 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
DE102010021962A1 (en) * 2010-05-28 2011-12-01 Siemens Aktiengesellschaft Medical implant for e.g. transplantation of tissue during surgery, has recesses forming geometrical pattern for determining location and position of implant based on two-dimensional X-ray images and independent of fluoroscopy direction
BR112013023320A2 (en) * 2011-03-29 2016-12-13 Terumo Corp stent and stent system
CN104352293A (en) * 2014-11-25 2015-02-18 北京航空航天大学 Drug eluting stent capable of reducing late thrombosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049810A1 (en) 1998-03-27 1999-10-07 Intratherapeutics, Inc. Stent
US6159237A (en) 1996-02-14 2000-12-12 Inflow Dynamics, Inc. Implantable vascular and endoluminal stents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159237A (en) 1996-02-14 2000-12-12 Inflow Dynamics, Inc. Implantable vascular and endoluminal stents
WO1999049810A1 (en) 1998-03-27 1999-10-07 Intratherapeutics, Inc. Stent

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9284409B2 (en) 2007-07-19 2016-03-15 Boston Scientific Scimed, Inc. Endoprosthesis having a non-fouling surface
US8900292B2 (en) 2007-08-03 2014-12-02 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers

Also Published As

Publication number Publication date
US20010032011A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
US20040088041A1 (en) Expandable stent with array of relief cuts
US20010032011A1 (en) Expandable stent with array of relief cuts
US20050283228A1 (en) Expandable stent with relief holes capable of carrying medicines and other materials
CA2144305C (en) A flexible stent having a pattern formed from a sheet of material
JP4790756B2 (en) Expandable stent with longitudinal flexibility
EP0991375B1 (en) Expandable stent with variable thickness
EP1266636B1 (en) An expandable endovascular stent
US8007528B2 (en) Bifurcated stent
US8956400B2 (en) Helical stent
US6132461A (en) Stent with dual support structure
KR100325267B1 (en) Articulating stent
US5843168A (en) Double wave stent with strut
US8382820B2 (en) Stent having helical elements
US6533807B2 (en) Radially-expandable stent and delivery system
KR100386784B1 (en) Expansive branch stent and its implantation method
EP1255507B1 (en) Stent matrix
EP1565129B1 (en) Expandable stents
US9427340B2 (en) Stent with protruding branch portion for bifurcated vessels
US20030176914A1 (en) Multi-segment modular stent and methods for manufacturing stents
CA2262292A1 (en) Bifurcated axially flexible stent
EP0799607A2 (en) Intravascular stent having flattened profile
JP2005066203A (en) Flexible stent which expands uniformly
AU716126B2 (en) An expandable endovascular stent
JP2005027909A (en) Flexible stent having excellent blood vessel followup ability and extendability, and gentle to blood vessel

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP